Covid JN.1 variant escaped new vaccine boosters: Study

60

New Delhi, March 19 (IANS) The latest set of Covid-19 vaccines offered no increased protection against the JN.1 variant, which continues to circulate, according to a study.

JN.1, from the lineage of Omicron, is an off-spin of BA.2.86.

The variant, first detected in Luxembourg in August, was classified as a variant of interest (VOI) by the World Health Organisation (WHO) due to its rapid spread.

The additional mutation L455S in the spike protein of JN.1 is believed to have provided the variant with immune-evasion properties.

The study, appearing on a preprint site and not peer-reviewed yet, examined the efficacy of XBB 1.5 boosters on the JN.1 variant among 76 people. The findings showed that the vaccine provided better coverage overall, but the globally dominant JN.1 managed to evade them.

“Remarkably, while many individual mutations that emerged between 2020 and 2022 exhibit escape from sera following primary vaccination, few escape boosted sera,” said Alejandro B. Balazs, from Ragon Institute of Massachusetts General Hospital, in the paper.

“An updated XBB.1.5 booster significantly increased titers against newer variants but not JN.1,” he added.

Importantly, the team also found that newly emerging Covid variants have “more efficient ways of entering cells”, besides the common entry point – ACE2.

“In addition to escape from vaccine sera, we found that mutations also contribute significantly to the ability of pseudovirus to infect cells, suggesting that variant selection is optimising both antibody escape and viral entry. We found that spikes from variants post BA.1 produced pseudoviruses that were up to 30-fold better at transducing target cells than wild-type, suggesting that WT SARS-CoV-2 spike was not optimally configured for ACE2-dependent viral entry,” the team said.

Although seasonal boosters improve immunity against new strains, the immune escape potential of the “variants demonstrate the need for novel approaches to adequately control SARS-CoV-2 transmission”, the team said.

–IANS

rvt/vd

Go to Source

Disclaimer

The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.

Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.

For any legal details or query please visit original source link given with news or click on Go to Source.

Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.

If you are not willing to accept this disclaimer then we recommend reading news post in its original language.

Online Cricket Play Online